Surgery
Volume 131, Issue 6 , Pages 591-593 , June 2002

Joint policy statement of the surgical journal editors on scientific data from clinical trials: Investigators' responsibilities and rights

,Accepted 11 March 2002.

References 

  1. Rutherford RB, Johnston KW. Potential problems with industry-supported research. J Vasc Surg. 2000;31:1066–1076
  2. Weatherall D. Academia and industry: increasingly uneasy bedfellows. Lancet. 2000;355:1574
  3. Angell M. Is academic medicine for sale?. N Engl J Med. 2000;342:1516–1518
  4. Bodenheimer T. Uneasy alliance—clinical investigators and the pharmaceutical industry. N Engl J Med. 2000;342:1539–1544
  5. Goldstein LB, Brott TG, Kothari RU, Smith WS. Clinical stroke trials: guarding against bias. Stroke. 1999;30:1165–1166
  6. Hailey D. Scientific harassment by pharmaceutical companies: time to stop. CMAJ. 2000;162:212–213
  7. Rennie D. Fair conduct and fair reporting of clinical trials. JAMA. 1999;282:1766–1768
  8. Kahn JO, Cheng DW, Mayer K, Murray H, Lagakos S. Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 5493106/L CD4 cell counts: a randomized controlled trial. JAMA. 2000;284:2193–2202
  9. Blumenthal D, Campbell EG, Anderson MS, Causino N, Louis KS. Withholding research results in academic life science: evidence from a national survey of faculty. JAMA. 1997;277:1224–1228
  10. Rutherford RB, Johnston KW. Protecting the rights of investigators in industry supported clinical research. J Vasc Surg. 2002; In press
  11. Davidoff F, DeAngelis CD, Drazen JM, nicholls MG, Hoey J, Hojgaard L, et al.  Sponsorship, authorship, and accountability. N Engl J Med. 2001;345:825

☆ This document is not covered by copyright. It may be copied or reprinted without permission.

PII: S0039-6060(02)00000-4

doi: 10.1067/msy.2002.125349

Surgery
Volume 131, Issue 6 , Pages 591-593 , June 2002

Article Tools